Initial Intraosseous or Intravenous Access for Out-of-Hospital Cardiac Arrest. Reply [0.03%]
院外心脏骤停的初始骨内或静脉通道建立。对论著《初期骨内通道与静脉通道建立》的评论
Keith Couper,Rachael T Fothergill,Gavin D Perkins
Keith Couper
Initial Intraosseous or Intravenous Access for Out-of-Hospital Cardiac Arrest [0.03%]
院前心脏骤停的初始骨内通路或静脉通路急救
Hans van Schuppen,Patrick Schober
Hans van Schuppen
Initial Intraosseous or Intravenous Access for Out-of-Hospital Cardiac Arrest [0.03%]
院外心脏骤停的初期骨内或静脉通道急救
Joshua R Lupton,Jonathan Jui,Mohamad R Daya
Joshua R Lupton
Glofitamab with Polatuzumab Vedotin in Refractory Burkitt's Lymphoma [0.03%]
吉奥夫塔马布联合波洛妥珠单抗 vedotin 治疗难治性伯基特淋巴瘤
Anca Prica,Mark Roschewski,Peter Beale et al.
Anca Prica et al.
The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption [0.03%]
IARC关于减少酒精消费政策影响的观点
Susan M Gapstur,Daniela Mariosa,Luciana Neamtiu et al.
Susan M Gapstur et al.
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation [0.03%]
房颤监测装置检测到的房颤抗凝或抗血小板治疗
Sarah Gorey,Jeff S Healey,Paulus Kirchhof
Sarah Gorey
Mark T Dransfield,Daiana Stolz
Mark T Dransfield
Alessandro Aiuti
Alessandro Aiuti
Mary Frances McMullin
Mary Frances McMullin
Targeting Lipoprotein(a) - the Next Frontier in Cardiovascular Disease [0.03%]
靶向载脂蛋白(a)——心血管疾病治疗的新前沿
Daniel J Rader
Daniel J Rader